4.7 Article

The Case for Why Africa Should Host COVID-19 Candidate Vaccine Trials

Journal

JOURNAL OF INFECTIOUS DISEASES
Volume 222, Issue 3, Pages 351-355

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiaa303

Keywords

COVID-19; vaccine trials; ethics; public health; global health

Funding

  1. Centre for the AIDS Programme of Research in South Africa
  2. HIV Prevention Trial Network
  3. Bill and Melinda Gates Foundation

Ask authors/readers for more resources

In response to provocative comments by 2 European clinicians and scientists, the World Health Organization Director General has declared that Africa will not host COVID-19 vaccine trials. Such a stance risks stigmatizing COVID-19 vaccine trials in Africa and depriving Africa of critical research. To the contrary, there is a critical need for Africa to host COVID-19 vaccine trials on public health, scientific, and ethics grounds.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available